Severe spruelike enteropathy due to olmesartan;Enteropatía grave similar a la enfermedad celiaca debido al olmesartán

Revista Espanola de Enfermedades Digestivas

Volumn 106, Issue 2, 2014, Pages 142-144

  Fiorucci, Gioia ^a   Puxeddu, Efisio ^a   Colella, Renato ^a   Reboldi, Gian Paolo ^a   Villanacci, Vincenzo ^b   Bassotti, Gabrio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Celiac disease; Diarrhea; Enteropathy; Histology; Olmesartan

Indexed keywords

ALBUMIN; CALCIUM; CD3 ANTIBODY; CONTRAST MEDIUM; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; HLA DQ2 ANTIGEN; LOPERAMIDE; MAGNESIUM; OLMESARTAN; PHOSPHORUS; POTASSIUM; PREALBUMIN; PROTEIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

AGED; ANOREXIA; BILIARY SLUDGE; BLOOD CHEMISTRY; BODY WEIGHT DISORDER; CASE REPORT; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; DEHYDRATION; DIARRHEA; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOSCOPY; ENTERITIS; ERYTHEMA; GASTRITIS; HEPATOMEGALY; HISTOLOGY; HLA TYPING; HUMAN; HUMAN TISSUE; HYPOKALEMIA; INTESTINE VILLUS ATROPHY; LYMPHADENOPATHY; LYMPHOCYTIC COLITIS; LYMPHOCYTIC ENTERITIS; LYMPHOCYTIC GASTRITIS; MALE; MUCOSAL DISEASE; NOTE; PARENTERAL NUTRITION; PHYSICAL ACTIVITY; QUESTIONNAIRE; STEATOSIS; CELIAC DISEASE; CHEMICALLY INDUCED; INTESTINE MUCOSA; PATHOLOGY;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CELIAC DISEASE; HUMANS; IMIDAZOLES; INTESTINAL MUCOSA; MALE; TETRAZOLES;

EID: 84907272895     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082014000200011     Document Type: Note

References (18)

1. DeGaetani M, Tennyson CA, Lebwohl B, Lewis SK, Abu Daya H, Arguelles-Grande C, et al. Villous atrophy and negative celiac serology: A diagnostic and therapeutic dilemma. Am J Gastroenterol 2013; 108: 647-53.
2. Krauss N, Schuppan D. Monitoring nonresponsive patients who have celiac disease. Gastrointest Endosc Clin N Am 2006; 16: 317-27.
3. Kwo PY, Tremaine WJ. Nonsteroidal anti-inflammatory drug-induced enteropathy: Case discussion and review of the literature. Mayo Clin Proc 1995; 70: 55-61.
4. Ziegler TR, Fernández-Estívariz C, Gu LH, Fried MW, Leader LM. Severe villus atrophy and chronic malabsorption induced by azathioprine. Gastroenterology 2003; 124: 1950-7.
5. Kamar N, Faure P, Dupuis E, Cointault O, Joseph-Hein K, Durand D, et al. Villous atrophy induced by mycophenolate mofetil in renaltransplant patients. Transpl Int 2004; 17: 463-7.
6. Weclawiak H, Ould-Mohamed A, Bournet B, Guilbeau-Frugier C, Fortenfant F, Muscari F, et al. Duodenal villous atrophy: A cause of chronic diarrhea after solid-organ transplantation. Am J Transplant 2011; 11: 575-82.
7. Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012; 87: 732-8.
8. Dreifuss SE, Tomizawa Y, Farber NJ, Davison JM, Sohnen AE. Spruelike enteropathy associated with olmesartan: An unusual case of severe diarrhea. Case Rep Gastrointest Med 2013; 2013: 618071.
9. Stanich PP, Yearsley M, Meyer MM. Olmesartan-associated sprue-like enteropathy. J Clin Gastroenterol 2013 (in press).
10. Rubio-Tapia A, Talley NJ, Gurudu SR, Wu TT, Murray JA. Glutenfree diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol 2010; 8: 344-9. e3.
11. FDA Drug Safety Communication: FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil. Available at: http://www. fda. gov/Drugs/DrugSafety/ucm359477. htm.
12. Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994; 93: 2431-7.
13. Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, et al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation 2009; 120: 526-32.
14. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F. Regulatory T cells and intestinal homeostasis. Immunol Rev 2005; 204: 184-94.
15. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005; 307: 1920-5.
16. Casella G, Villanacci V, Fisogni S, Cambareri AR, Di Bella C, Corazzi N, et al. Colonic left-side increase of eosinophils: A clue to drugrelated colitis in adults. Aliment Pharmacol Ther 2009; 29: 535-41.
17. Villanacci V, Casella G, Bassotti G. The spectrum of drug-related colitides: Important entities, though frequently overlooked. Dig Liver Dis 2011; 43: 523-8.
18. Villanacci V, Manenti S, Antonelli E, Chiudinelli M, Giuliano V, Bassotti G. Non-IBD colitides: Clinically useful histopathological clues. Rev Esp Enferm Dig 2011; 103: 366-72.